Keyphrases
Advance Care Planning
100%
Coaching
100%
Non-small Cell Lung Cancer (NSCLC)
66%
Metastatic Cancer
41%
Machine Learning
41%
Patients with Cancer
36%
Palliative Care
36%
Lay Care
33%
Unlearning
33%
Changing Clinical Practice
33%
Randomized Clinical Trial
33%
Physician Experience
33%
Cost-effectiveness
33%
Neuroendocrine Neoplasms
33%
Enteropancreatic
33%
Health Care Costs
33%
Lanreotide
33%
Neuroendocrine Tumor
33%
Lung Biomarkers
33%
Out-of-pocket Expenditure
33%
Biomarker Testing
33%
Lung Cancer Treatment
33%
Failure Pattern
33%
Lung Cancer Outcomes
33%
Single Institution
33%
Retrospective Analysis
33%
Planning Documentation
33%
Patient Selection
33%
Patient Care
33%
Terminal Illness
33%
Serious Illness Communication
25%
Progression-free Survival
24%
Systemic Therapy
22%
Non-small Cell Lung Cancer Patients
22%
Overall Survival
22%
Neoadjuvant Therapy
22%
Intergroup Difference
22%
Stage III Non-small Cell Lung Cancer
22%
Clinical Practice
20%
Quality-adjusted Life Years
20%
Odds Ratio
16%
Adjusted Odds Ratio
16%
Disease Stage
16%
Former Smokers
15%
Incremental Cost-effectiveness Ratio
13%
Treatment Options
13%
Oncology
12%
Electronic Health Records
12%
High Risk
11%
Somatostatin Analogs
11%
Medicine and Dentistry
Advance Care Planning
100%
Diseases
55%
Clinician
54%
Metastatic Carcinoma
41%
Symptomatic Treatment
40%
Neuroendocrine Tumor
33%
Health Care Cost
33%
Randomized Clinical Trial
33%
Non Small Cell Lung Cancer
33%
Cancer Therapy
33%
Odds Ratio
33%
Patient Care
33%
Patient Selection
33%
Cancer
33%
Progression Free Survival
16%
Overall Survival
16%
Neoadjuvant Therapy
11%
Systemic Therapy
10%
Oncology
10%
Electronic Health Record
9%
Malignant Neoplasm
9%
Oncologist
8%
Urogenital Tract Cancer
6%
Emergency Department
6%
Side Effect
6%
Therapeutic Agent
6%
Supportive Care
6%
Chemoradiotherapy
5%
Chi Square Test
5%
Immunotherapy
5%
Retrospective Study
5%
Neoadjuvant Chemotherapy
5%
Somatostatin Derivative
5%
Nursing and Health Professions
Advance Care Planning
100%
Diseases
33%
Clinical Practice
33%
Neuroendocrine Tumor
33%
Odds Ratio
33%
Patient Care
33%
Patient Selection
33%
Systemic Therapy
22%
Electronic Health Record
12%
Somatostatin Derivative
11%
Oncologist
8%
Randomization
6%
Emergency Ward
6%
Palliative Therapy
6%
Urogenital Tract Cancer
6%
General Practitioner
5%
Tumor Differentiation
5%
Current Procedural Terminology
5%
Primary Tumor
5%
Medicare
5%
Malignant Neoplasm
5%
